Adaptive Biotechnologies
Public
Seattle-based Adaptive Biotechnologies provides life science equipment for disease diagnosis and monitoring in the US.
Founded
2009Adaptive Biotechnologies Corporation, founded in Seattle, Washington, is a commercial-stage company focused on revolutionizing disease diagnosis and treatment through its immune medicine platform. The company's core mission is to harness the adaptive immune system's power to detect and fight diseases, often before symptoms appear. Its primary products include immunoSEQ, a platform for answering translational research questions and discovering new diagnostic signals, and clonoSEQ, a clinical diagnostic tool for monitoring minimal residual disease in multiple myeloma patients.
Notable affiliated individuals include co-founders Chad Robins and Harlan Robins. The company has attracted significant investment from firms like Viking Global Investors and Matrix Capital Management. Key achievements include FDA approval for clonoSEQ and partnerships with major pharmaceutical companies to advance immune-driven therapies. Adaptive Biotechnologies has made a substantial impact by enabling more precise disease monitoring and fostering advancements in personalized medicine.
Adaptive Biotechnologies - Similar Companies
Adaptive Biotechnologies - Quick Facts
Who are Adaptive Biotechnologies' competitors?
Companies similar to Adaptive Biotechnologies include Seagen, HI-Bio, Mission Bio and Fluidigm.
When was Adaptive Biotechnologies founded?
Adaptive Biotechnologies was founded in 2009.
Where is Adaptive Biotechnologies' headquarters located?
Adaptive Biotechnologies' headquarters is located in Seattle, WA, US.
When was Adaptive Biotechnologies' last funding round?
Adaptive Biotechnologies' most recent funding round was for $125M (USD) in September 2022.
How much has Adaptive Biotechnologies raised to-date?
As of Sep 12, 2022, Adaptive Biotechnologies has raised a total of $531.9M (USD).
How many employees does Adaptive Biotechnologies have?
Adaptive Biotechnologies has 790 employees as of Feb 6, 2024.
Adaptive Biotechnologies - Classification
- Model
- Customer
- Main Product
- Unique IDs
- secCik: 0001478320
- ticker: ADPT
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541500Computer Systems Design and Related Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541510Computer Systems Design and Related Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- 541511Custom Computer Programming Services
- SIC
- 2836Biological Products, Except Diagnostic Substances
- 2800Chemicals And Allied Products
- 7300Business Services
- 2830Drugs
- 7370Computer Programming, Data Processing, And Other Computer Related
- 7371Computer Programming Services
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 21 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325414Biological Product (except Diagnostic) Manufacturing
- 513200Software Publishers
- 510000Information
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 513000Publishing Industries
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 513210Software Publishers
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 2834Pharmaceutical Preparations
- 7372Prepackaged Software
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research